https://biodexapharma.com/publications/ 2023-10-09T16:20:06+00:00 https://biodexapharma.com/publications/printing-particles-a-high-throughput-technique-for-the-production-of-uniform-bioresorbable-polymer-microparticles-and-encapsulation-of-therapeutic-peptides/ 2023-05-22T10:08:16+00:00 https://biodexapharma.com/publications/conlon-efficacy-of-soluble-panobinostat-mtx110-in-preclinical-models-of-adult-glioblastoma/ 2023-09-13T13:34:26+00:00 https://biodexapharma.com/wp-content/uploads/efficacy-soluble-panobinostat-mtx110-pre-clinical-figure-1.jpg https://biodexapharma.com/wp-content/uploads/efficacy-soluble-panobinostat-mtx110-pre-clinical-figure-2.jpg https://biodexapharma.com/wp-content/uploads/efficacy-soluble-panobinostat-mtx110-pre-clinical-figure-3.jpg https://biodexapharma.com/publications/a-phase-i-study-examining-the-feasibility-of-intermittent-convection-enhanced-delivery-ced-of-mtx110-for-the-treatment-of-children-with-newly-diagnosed-diffuse-midline-gliomas/ 2023-09-13T14:20:09+00:00 https://biodexapharma.com/wp-content/uploads/mtx110-203_dipg_trial-figure-1.jpg https://biodexapharma.com/wp-content/uploads/mtx110-203_dipg_trial-figure-2.jpg https://biodexapharma.com/wp-content/uploads/mtx110-203_dipg_trial-figure-3.jpg https://biodexapharma.com/wp-content/uploads/mtx110-203_dipg_trial-figure-4.jpg https://biodexapharma.com/wp-content/uploads/mtx110-203_dipg_trial-figure-5.jpg https://biodexapharma.com/publications/high-dose-mtx110-soluble-panobinostat-safely-administered-into-the-fourth-ventricle-in-a-non-human-primate-model/ 2023-09-14T15:15:10+00:00 https://biodexapharma.com/wp-content/uploads/mtx110-4th-ventricle-primate-figure-1.jpg https://biodexapharma.com/wp-content/uploads/mtx110-4th-ventricle-primate-figure-2.jpg https://biodexapharma.com/wp-content/uploads/mtx110-4th-ventricle-primate-figure-3.jpg https://biodexapharma.com/wp-content/uploads/mtx110-4th-ventricle-primate-figure-4.jpg https://biodexapharma.com/wp-content/uploads/mtx110-4th-ventricle-primate-figure-5.jpg https://biodexapharma.com/publications/pnoc015-an-open-label-single-arm-study-of-mtx110-delivered-by-convection-enhanced-delivery-ced-in-patients-with-diffuse-intrinsic-pontine-glioma-dipg-previously-treated-with-external-beam-radiati/ 2023-09-14T15:36:35+00:00 https://biodexapharma.com/wp-content/uploads/mtx110-dpig-trial-figure-1.jpg https://biodexapharma.com/wp-content/uploads/mtx110-dpig-trial-figure-2.jpg https://biodexapharma.com/wp-content/uploads/mtx110-dpig-trial-figure-3.jpg https://biodexapharma.com/wp-content/uploads/mtx110-dpig-trial-figure-4.jpg https://biodexapharma.com/publications/singleton-et-al-the-distribution-clearance-and-brainstem-toxicity-of-panobinostat-administered-by-convection-enhanced-delivery/ 2023-10-09T16:20:06+00:00 https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-table-1.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-table-2.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-table-3.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-table-4.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-figure-1.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-figure-2.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-figure-3.jpg https://biodexapharma.com/wp-content/uploads/distribution-toxicity-panobinostat-figure-4.jpg